Showing results (1121-1130 of 3,153) with videos related to
Sort By:
Pageof 316
Neuro-Oncology|December 15, 2020
Tumor cell network integration in glioma represents a stemness featureRuifan Xie, Tobias Kessler, Julia Grosch, et al.Neuro-Oncology|December 15, 2020
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell deliveryDalia Haydar, Haley Houke, Jason Chiang, et al.Neuro-Oncology|December 21, 2020
High frequency of disease progression in pediatric spinal cord low-grade glioma (LGG): management strategies and results from the German LGG study groupThomas Perwein, Martin Benesch, Daniela Kandels, et al.Neuro-Oncology|December 21, 2020
Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017Nirav Patil, Michael E Kelly, Debra Nana Yeboa, et al.Neuro-Oncology|December 28, 2020
H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohortFelix Behling, Christina Fodi, Irina Gepfner-Tuma, et al.Neuro-Oncology|April 12, 2013
Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research GroupSun-Ho Lee, Chun Kee Chung, Chi Heon Kim, et al.Neuro-Oncology|April 12, 2013
ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitroJing Xiong, Li Zhou, Miao Yang, et al.Neuro-Oncology|April 16, 2013
Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycinFranz J Zemp, Xueqing Lun, Brienne A McKenzie, et al.Neuro-Oncology|March 19, 2013
Rituximab is associated with improved survival for aggressive B cell CNS lymphomaGareth Gregory, Ashwini Arumugaswamy, Teresa Leung, et al.Neuro-Oncology|March 23, 2013
Secondary hematological malignancies associated with temozolomide in patients with gliomaHiroyuki Momota, Yoshitaka Narita, Yasuji Miyakita, et al.Pageof 316